| Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunction. | |
| | |
MedLine Citation:
|
PMID: 19060788 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Mild-to-moderate therapeutic hypothermia after resuscitation from cardiac arrest is neuroprotective, but its effect on postresuscitation myocardial dysfunction is not clear. We hypothesized that therapeutic hypothermia is cardioprotective in postresuscitation. Male adult Wistar rats underwent asphyxia-induced cardiac arrest and manual resuscitation with epinephrine. Therapeutic hypothermia is induced immediately after successful resuscitation and the return of spontaneous circulation (ROSC). One hour after ROSC, the rats achieved a target temperature of 30 degrees C to 31 degrees C, which was maintained for 1.5 h and then transitioned to the passive rewarming process in the hypothermia group. A temperature between 36.5 degrees C and 37.5 degrees C was maintained in the normothermia group. Echocardiography revealed that hypothermia resulted in significantly better systolic function of fractional shortening in 60 and 120 min after ROSC (both P < 0.05). The benefit of cardioprotection was also confirmed by the general linear mixed-models analysis of dP/dt, which revealed significantly better systolic function in positive dP/dtR(40) and diastolic function in maximal negative dP/dt (both P < 0.001). The 4-h and 3-day survival analyses both revealed better outcomes in the hypothermia groups in the log-rank test (P < 0.001 for the 4-h analysis, and P < 0.05 for the 3-day analysis). Serum level of heart-type, fatty acid-binding protein at 4 h after resuscitation as the myocardium damage marker was also significantly lower in the hypothermia group (52.4 ng/mL vs 186.5 ng/mL in the normothermia group; P < 0.05). Western blotting of myocardium showed that myocardial Akt and ERK1/2 were more activated in the hypothermia group 2 h after spontaneous circulation returned. In conclusion, postresuscitation mild-to-moderate therapeutic hypothermic is cardioprotective in the asphyxia-induced cardiac arrest animal model. It stabilizes hemodynamics, improves short-term survival, and decreases myocardial damage. The cardioprotective effect is associated with Akt and ERK1/2 activation in signal transduction. |
| | |
Authors:
|
Chiung-Yuan Hsu; Chien-Hua Huang; Wei-Tien Chang; Huei-Wen Chen; Hsiao-Ju Cheng; Min-Shan Tsai; Tzung-Dau Wang; Zui-Shen Yen; Chien-Chang Lee; Shyr-Chyr Chen; Wen-Jone Chen |
Related Documents
:
|
2551008 - Flunarizine i.v. after cardiac arrest (fluna-study): study design and organisational as... 7838188 - Developmental and neurologic status of children after heart surgery with hypothermic ci... 1138178 - Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital v... 10555178 - Single breath-hold slice-following cspamm myocardial tagging. 1403238 - Myocardial fibrosis and the concepts of cardioprotection and cardioreparation. 22322578 - New therapies for cardiogenic shock. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Shock (Augusta, Ga.) Volume: 32 ISSN: 1540-0514 ISO Abbreviation: Shock Publication Date: 2009 Aug |
Date Detail:
|
Created Date: 2009-07-16 Completed Date: 2009-10-01 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 9421564 Medline TA: Shock Country: United States |
Other Details:
|
Languages: eng Pagination: 210-6 Citation Subset: IM |
Affiliation:
|
Department of Emergency Medicine, National Taiwan University Medical College and Hospital, Taipei, Taiwan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Asphyxia / blood, complications, therapy, ultrasonography Echocardiography Epinephrine / pharmacology* Fatty Acid-Binding Proteins / blood Heart Arrest / blood, etiology, therapy*, ultrasonography Hypothermia, Induced* Male Mitogen-Activated Protein Kinase 1 / metabolism Mitogen-Activated Protein Kinase 3 / metabolism Myocardium / metabolism Proto-Oncogene Proteins c-akt / metabolism Rats Rats, Wistar Resuscitation* Signal Transduction / drug effects Sympathomimetics / pharmacology* Systole / drug effects Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/FABP3 protein, rat; 0/Fatty Acid-Binding Proteins; 0/Sympathomimetics; 51-43-4/Epinephrine; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.11.24/Mitogen-Activated Protein Kinase 1; EC 2.7.11.24/Mitogen-Activated Protein Kinase 3 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Whole-body CO2 production as an index of the metabolic response to sepsis.
Next Document: Quantification of aortic valve stenosis: head-to-head comparison of 64-slice spiral computed tomogra...